REQUEST A DEMO
Total
USD $0.00
Search more companies

Ogaret Pharm, S.R.O. (Czech Republic)

Main Activities: Pharmacies and Drug Stores | Advertising Agencies
Full name: Ogaret Pharm, S.R.O. Profile Updated: August 25, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Ogaret Pharm, S.R.O. is based in Czech Republic. The head office is in Prague. It operates in the Pharmacies and Drug Stores sector. Ogaret Pharm, S.R.O. was incorporated on October 09, 2023. 10 - 19 (2026) employees currently work for Ogaret Pharm, S.R.O.. From the latest financial highlights, Ogaret Pharm, S.R.O. reported a net sales revenue drop of 2.92% in 2025. A growth of 11.73% was recorded in its total assets. The net profit margin of Ogaret Pharm, S.R.O. increased by 0.01% in 2025.

Headquarters
Bilkova 855/19
Prague; The City of Prague; Postal Code: 11000

Contact Details: Purchase the Ogaret Pharm, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Ogaret Pharm, S.R.O. report to view the information.
Registered Capital:
Purchase the Ogaret Pharm, S.R.O. report to view the information.
Financial Auditors:
Purchase the Ogaret Pharm, S.R.O. report to view the information.
Incorporation Date:
October 09, 2023
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Ogaret Pharm, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-2.92%▼
Total Operating Revenue
-2.92%▼
Operating Profit
2.67%▲
Net Profit/Loss for the Period
-2.45%▼
Total Assets
11.73%▲
Total Equity
N/A
Operating Profit Margin
0.11%▲
Net Profit Margin
0.01%▲
Return on Equity (ROE)
N/A
Quick Ratio
0.59%▲
Cash Ratio
0.2%▲

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?